Development Michrosphere Bioadhesive Delivery System From Secondary Metabolit Actynomycetes M10a Rhizosphere Mangrove As Supportive Therapy of Colon Cancer Patients

Authors

  • Fajrin Hasan Basri

Abstract

Colon cancer is a cancer that occurs in the large intestine when abnormal cells grow
in the colon or rectum layer.  Inflammation Symptoms  in the colon are usually characterized
by a polyp that has cancer risk. Approximately 96% of colon cancer cases are caused by
adenocarcinomas that develop from the glandular tissue. Utilization of secondary metabolites
from Actynomycetes Mangrove forests can be used as supportive therapy for colon cancer
patients that have already through apoptotic testing so it can directly treat the target of illness.
This  study was prepared in the form of  Michrosphere Bioadhesive  using secondary
metabolite  Actynomycetes M10a rhizosphere mangrove. The purpose of this study was to
obtain the development of  Michosphere Bioadhesive  preparations from secondary
metabolites  Actynomycetes M10a  rhizosphere mangrove  as supportive therapy for colon
cancer patients. Method of the research is base on Laboratory experiment which started with
Purification  of  Actynomycetes  isolate, Secondary Metabolite Fermentation,  Michrosphere
Bioadhesive  Formulation and evaluation of  Michrosphere  Bioadhesive  preparation. The
concentration of secondary metabolite Actynomycetes M10a rhizosphere mangrove that been
used for each formula are 400 μl, 500 μl, and 600 μl, where the percentage of submerged in
F1, F2, and F3 are 93,94%, 96,96%, and 94, respectively, 12%. Particular Particle Size
Distribution is F1 (3.1μm), F2 (4.4 μm), F3 (3.9 μm). The rest angles obtained are F1
(0.002O), F2 (0.002O), F3 (0.0016O), respectively. Applied efficiency was obtained by F1
(214 nm), F2 (210 nm), F3 (211 nm). Dissolution results show the absorbance results at 266
nm wavelength. From the results obtained that meet the specifications seen in Formula 2.
 
Keywords: Colon Cancer,  Actynomycetes  M10a  rhizosphere mangrove, Michosphere
Bioadhesive.

References

Arora, A., M.G. Nair, and G.M. Strasburg. 1998. Structure–activity relationshipsfor

antioxidant activities of a series of flavonoids in a liposomal system.Free Radic.

Biol. & Med. 24(9): 1355-1363.

Alteri, R. et al. (2011). Colorectal Cancer Facts & Figure 2011-2013. Atlanta:American

Cancer Society.

Balaji, S. M. 2009. Textbook of Oral and Maxillofacial Surgery. New Delhi:Elsevier.

De Vita, Vincent T, Hellman, Samuel Rosemberg, Steven A.2011b. CancerPrincipies &

Practice of oncology, 9th

Lippincott Williams & Wilkins.

Depkes RI. 2013. Riset Kesehatan Dasar (Riskesdas) 2013. Jakarta : Badan

Penelitian dan Pengembangan Kesehatan Kementrian Kesehatan.

Dipiro.JT., 2009, Pharmacoterapy Handbook 7th edition, Mc Graw Hill, New York.

El-Hady, H.H.A., S.M. Daboor, & A.E. Ghoniemy. 2007. Nutritive andantimicrobial

profles of some seagrass from bardawil lake. Egyptian J.Aq. Research 33: 103 -

Mangan Y. 2009. Cara Bijak Menaklukkan Kanker. Jakarta: AgroMedia Pustaka.

Oskoueian E, et al. 2011; Huang et al. 2014.Antioxidant, antiinflammatory and

cytotoxicity of Phaleria macrocarpa (Boerl.) scheff fruit. BMC Complementary

and Alternative Medicine 2011; 110-119

Parmar, et.al., 2010. Different Methods Of Formulation And Evaluation Of Mucoadhesive

Microsphere. Vol 1. Department of quality assurance:India.

Pendyala, Yamini dan Sudha Talasila, 2012, Formulation And Evaluation OfBioadhesive

Microsphere Of Ramipril,International Journal of Pharmaceutical and Chemical

Sciences Vol.1.

Saija, A. et al.,1995, Flavonoids as Antioxidant Agents: Importance of TheirInteraction

with Biomembranes, Free Radic. Biol. & Med. 19(4): 481-486.

Downloads

Published

2018-07-28